Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide

NCT00162760 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT00162760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00162760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2003
Completion date
July 31, 2007
Enrollment
19
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic pulmonary fibrosis (ipf)